Latanoprost combined with Xalatan

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Systemic Lupus Erythematosus Other Serious 64 Female 12/31/2008 Japan
Primary
Concomitant
Thyroglossal Cyst Other Serious 8/8/2001 40 Male 227 lb 4/15/2009 United States
Primary
Concomitant
Wound Infection Hospitalization 73 Male 1/22/2010 United States
Primary
Concomitant
Myocardial Infarction Hospitalization 2/1/2010 72 Male 170 lb 8/23/2010 Consumer United States
Primary
Secondary
Concomitant
Device Issue Male 160 lb 9/20/2010 Consumer United States
Primary
Secondary
Concomitant
Pruritus Female 200 lb 9/22/2010 Consumer United States
Primary
Secondary
Concomitant
Eye Irritation Female 9/22/2010 Consumer United States
Primary
Secondary
Pruritus Female 200 lb 9/27/2010 Consumer United States
Primary
Secondary
Concomitant
Sinus Disorder Female 230 lb 10/6/2010 Consumer United States
Primary
Secondary
Concomitant
Eye Irritation Male 175 lb 10/22/2010 Consumer United States
Primary
Secondary
Concomitant
Sinus Disorder Female 229 lb 11/5/2010 Physician United States
Primary
Secondary
Concomitant
Intraocular Pressure Increased Other Serious 1/1/2009 Female 11/9/2010 Consumer Greece
Primary
Secondary
Intraocular Pressure Increased Other Serious 64 Female 11/17/2010 Consumer Brazil
Primary
Secondary
Concomitant
Throat Irritation Female 11/24/2010 Consumer United States
Primary
Secondary
Tremor Female 12/7/2010 Consumer United States
Primary
Secondary
Eye Irritation Male 175 lb 12/10/2010 Consumer United States
Primary
Secondary
Concomitant
Intraocular Pressure Increased Other Serious 64 Female 12/21/2010 Consumer Brazil
Primary
Secondary
Concomitant
Product Substitution Issue Other Serious 49 Female 12/30/2010 Consumer Brazil
Primary
Secondary
Concomitant
Throat Irritation Female 1/5/2011 Consumer United States
Primary
Secondary
Atrial Fibrillation Hospitalization 12/31/2010 71 Female 162 lb 1/12/2011 Physician United States
Primary
Concomitant
Drug Dose Omission Hospitalization 12/31/2010 71 Female 162 lb 1/17/2011 Physician United States
Primary
Concomitant
Blood Glucose Increased Female 190 lb 1/24/2011 Consumer United States
Primary
Concomitant
Dry Eye Other Serious Female 1/28/2011 Consumer United States
Primary
Concomitant
Atrial Fibrillation Hospitalization 12/31/2010 71 Female 162 lb 1/28/2011 Physician United States
Primary
Concomitant
Skin Discolouration 2/1/2009 83 Female 135 lb 2/17/2011 Consumer United States
Primary
Secondary
Device Ineffective 90 Female 2/17/2011 Physician United States
Primary
Secondary
Drug Dose Omission Female 101 lb 2/17/2011 Consumer United States
Primary
Secondary
Concomitant
Incorrect Dose Administered Female 113 lb 2/17/2011 Consumer United States
Primary
Secondary
Concomitant
Intraocular Pressure Fluctuation Male 269 lb 2/22/2011 Consumer United States
Primary
Secondary
Concomitant
Therapeutic Product Ineffective 4/1/2010 81 Male 190 lb 2/22/2011 Physician United States
Primary
Secondary
Concomitant
Expired Drug Administered Female 145 lb 2/22/2011 Consumer United States
Primary
Secondary
Concomitant
Product Substitution Issue Hospitalization 11/22/2010 79 Female 2/14/2011 Physician Australia
Primary
Secondary
Concomitant
Nasopharyngitis Female 2/28/2011 Consumer United States
Primary
Secondary
Glaucoma Other Serious 1/1/2004 Female 3/3/2011 Consumer United States
Primary
Secondary
Blood Glucose Increased Female 190 lb 3/9/2011 Consumer United States
Primary
Concomitant
Visual Acuity Reduced Disability Male 176 lb 3/9/2011 Consumer United States
Primary
Secondary
Concomitant
Visual Acuity Reduced Other Serious Male 176 lb 3/14/2011 Consumer United States
Primary
Secondary
Concomitant
Eye Disorder Female 145 lb 3/14/2011 Consumer United States
Primary
Secondary
Concomitant
Blood Glucose Increased Female 190 lb 3/16/2011 Consumer United States
Primary
Concomitant
Eye Disorder Other Serious 2/1/2011 Female 3/30/2011 Consumer United States
Primary
Secondary
Intraocular Pressure Increased Other Serious 3/29/2011 Female 4/2/2011 Consumer United States
Primary
Secondary
Dry Eye Other Serious 2/1/2011 78 Female 4/5/2011 Consumer United States
Primary
Secondary
Expired Drug Administered Female 4/7/2011 Consumer United States
Primary
Secondary
Atrial Fibrillation Hospitalization 12/31/2010 71 Female 162 lb 4/18/2011 Physician United States
Primary
Concomitant
Eye Disorder Female 145 lb 4/19/2011 Physician United States
Primary
Secondary
Concomitant
Visual Acuity Reduced Other Serious Female 4/25/2011 Consumer United States
Primary
Secondary
Eye Disorder Female 145 lb 4/25/2011 Physician United States
Primary
Secondary
Concomitant
Nasopharyngitis Female 4/25/2011 Other Health Professional United States
Primary
Secondary
Eye Irritation Female 4/27/2011 Consumer United States
Primary
Secondary
Vision Blurred 4/1/2011 56 Female 146 lb 5/10/2011 Consumer United States
Primary
Secondary
Intraocular Pressure Increased Other Serious Female 135 lb 5/13/2011 Consumer United States
Primary
Secondary
Asthenopia Other Serious Female 5/13/2011 Consumer Japan
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2010 83 Female 100 lb 5/25/2011 Consumer United States
Primary
Secondary
Concomitant
Intraocular Pressure Increased Other Serious 3/29/2011 85 Female 125 lb 5/26/2011 Consumer United States
Primary
Secondary
Concomitant
Eye Infection Bacterial Other Serious 5/1/2011 63 Female 130 lb 5/26/2011 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective Female 5/30/2011 Consumer United States
Primary
Secondary
Vision Blurred 4/1/2011 56 Female 146 lb 5/30/2011 Physician United States
Primary
Secondary
Body Height Decreased Other Serious 1/1/2010 83 Female 100 lb 6/14/2011 Consumer United States
Primary
Secondary
Concomitant
Eye Irritation Female 6/14/2011 Consumer United States
Primary
Secondary
Intraocular Pressure Increased Other Serious Female 6/20/2011 Pharmacist United States
Primary
Secondary
Eye Infection Bacterial Other Serious 5/1/2011 63 Female 130 lb 6/20/2011 Consumer United States
Primary
Secondary
Concomitant
Eye Pain Other Serious 6/3/2011 81 Female 117 lb 6/24/2011 Consumer United States
Primary
Secondary
Concomitant
Abdominal Discomfort Other Serious Female 198 lb 6/29/2011 Consumer United States
Primary
Secondary
Intraocular Pressure Increased Other Serious 1/1/2011 79 Female 120 lb 6/29/2011 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective 1/1/2011 Female 6/28/2011 Pharmacist United States
Primary
Secondary
Abnormal Sensation In Eye Female 6/30/2011 Consumer United States
Primary
Secondary
Drug Ineffective Female 7/12/2011 Consumer United States
Primary
Secondary
Headache Other Serious 2/1/2011 79 Female 7/12/2011 Consumer United States
Primary
Secondary
Concomitant
Dry Eye 4/1/2011 72 Female 131 lb 7/13/2011 Consumer United States
Primary
Secondary
Concomitant
Ocular Hyperaemia 6/1/2011 59 Female 215 lb 7/13/2011 Consumer United States
Primary
Concomitant
Visual Impairment Male 7/18/2011 Other Health Professional United States
Primary
Secondary
Vitamin B12 Decreased 4/1/2011 72 Female 131 lb 7/19/2011 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective 1/1/2011 80 Female 7/27/2011 Pharmacist United States
Primary
Secondary
Concomitant
Drug Ineffective Other Serious 10/1/2009 66 Female 170 lb 7/28/2011 Consumer United States
Primary
Secondary
Ocular Hyperaemia Male 7/27/2011 Consumer United States
Primary
Secondary
Dry Skin Other Serious 5/1/2011 63 Female 130 lb 8/1/2011 Physician United States
Primary
Secondary
Concomitant
Nausea Other Serious Female 198 lb 8/1/2011 Consumer United States
Primary
Secondary
Vitamin B12 Decreased 4/1/2011 72 Female 131 lb 8/4/2011 Consumer United States
Primary
Secondary
Concomitant
Visual Impairment Male 8/9/2011 Other Health Professional United States
Primary
Secondary
Pruritus Generalised Other Serious 6/1/2011 56 Female 156 lb 8/8/2011 Consumer United States
Primary
Secondary
Concomitant
Cataract Other Serious 7/1/2011 62 Female 154 lb 8/9/2011 Consumer Hungary
Primary
Secondary
Concomitant
Bronchitis Other Serious 73 Female 8/16/2011 Consumer Brazil
Primary
Secondary
Muscle Twitching Female 112 lb 8/18/2011 Consumer United States
Primary
Secondary
Concomitant
Eye Irritation Female 8/22/2011 Other Health Professional United States
Primary
Secondary
Eye Laser Surgery Other Serious 69 Female 8/23/2011 Consumer Canada
Primary
Secondary
Concomitant
Eye Pruritus 8/22/2011 Consumer United States
Primary
Secondary
Eye Inflammation Other Serious 6/1/2011 78 Female 154 lb 8/24/2011 Consumer United States
Primary
Secondary
Concomitant
Arthritis Other Serious Female 179 lb 8/24/2011 Consumer United States
Primary
Secondary
Concomitant
Erythema 8/1/2011 Female 8/24/2011 Consumer United States
Primary
Secondary
Pruritus Female 8/25/2011 Physician United States
Primary
Secondary
Concomitant
Cataract Other Serious 10/1/2009 66 Female 170 lb 8/29/2011 Consumer United States
Primary
Secondary
Osteoarthritis Other Serious Male 8/30/2011 Other Health Professional United States
Primary
Concomitant
Aortic Valve Sclerosis Other Serious Male 9/7/2011 Other Health Professional United States
Primary
Concomitant
Hypersensitivity Other Serious 6/1/2011 56 Female 156 lb 9/6/2011 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious Female 9/9/2011 Consumer United States
Primary
Secondary
Arthritis Other Serious Female 179 lb 9/13/2011 Physician United States
Primary
Secondary
Concomitant
Eye Disorder Other Serious 1/1/2011 59 Female 168 lb 9/14/2011 Consumer Brazil
Primary
Secondary
Concomitant
Ocular Discomfort Other Serious 1/1/2011 71 Female 201 lb 9/15/2011 Consumer United States
Primary
Secondary
Concomitant
Death Death 9/1/2011 70 Male 9/20/2011 Consumer Brazil
Primary
Secondary
Eye Laser Surgery Other Serious 9/9/2011 72 Male 9/23/2011 Consumer Canada
Primary
Secondary
Concomitant
Visual Acuity Reduced Other Serious Male 9/23/2011 Consumer Canada
Primary
Secondary
Burning Sensation 1/1/2011 Female 9/28/2011 Consumer United States
Primary
Secondary
Hair Growth Abnormal 1/1/2011 78 Male 170 lb 10/4/2011 Physician United States
Primary
Secondary
Concomitant
Eye Laser Surgery Other Serious 9/9/2011 71 Male 10/6/2011 Consumer Canada
Primary
Secondary
Concomitant
Cataract Other Serious 1/1/2009 65 Female 170 lb 10/11/2011 Consumer United States
Primary
Secondary
Drug Ineffective 1/1/2011 80 Female 10/11/2011 Pharmacist United States
Primary
Secondary
Concomitant
Eye Disorder 9/1/2011 46 Female 148 lb 10/12/2011 Consumer United States
Primary
Secondary
Eye Operation Other Serious Male 10/17/2011 Consumer United States
Primary
Secondary
Eye Irritation Other Serious 8/1/2011 76 Female 90 lb 10/20/2011 Other Health Professional United States
Primary
Secondary
Concomitant
Visual Acuity Reduced Other Serious 62 Male 185 lb 10/21/2011 Consumer Canada
Primary
Secondary
Cataract Other Serious 1/1/2009 65 Female 170 lb 10/21/2011 Physician United States
Primary
Secondary
Death Death 9/1/2011 70 Male 10/26/2011 Consumer Brazil
Primary
Secondary
Atrial Fibrillation Hospitalization 12/31/2010 71 Female 162 lb 10/27/2011 Physician United States
Primary
Concomitant
Intraocular Pressure Increased Other Serious 9/13/2011 71 Female 10/27/2011 Consumer United States
Primary
Secondary
Concomitant
Cataract Other Serious 75 Male 10/28/2011 Consumer Canada
Primary
Secondary
Concomitant
Vision Blurred Other Serious 10/1/2009 66 Female 169 lb 10/28/2011 Physician United States
Primary
Secondary
Aortic Valve Incompetence Other Serious Male 10/28/2011 Lawyer United States
Primary
Concomitant
Intraocular Pressure Increased Other Serious 1/1/2009 65 Female 170 lb 10/31/2011 Other Health Professional United States
Primary
Secondary
Burning Sensation Other Serious Female 10/31/2011 Consumer Brazil
Primary
Secondary
Concomitant
Eye Disorder 9/1/2011 46 Female 148 lb 11/1/2011 Consumer United States
Primary
Secondary
Blindness Other Serious 66 Male 11/11/2011 Consumer Canada
Primary
Secondary
Atrial Fibrillation Hospitalization 12/31/2010 71 Female 162 lb 11/16/2011 Physician United States
Primary
Concomitant
Hair Growth Abnormal 9/1/2011 79 Male 170 lb 11/17/2011 Physician United States
Primary
Secondary
Concomitant
Eye Irritation Female 11/17/2011 Consumer United States
Primary
Secondary
Intraocular Pressure Increased Other Serious 9/13/2011 71 Female 11/20/2011 Consumer United States
Primary
Secondary
Concomitant
Dry Eye 9/15/2011 74 Female 11/21/2011 Other Health Professional United States
Primary
Secondary
Eye Disorder 9/1/2011 46 Female 148 lb 11/30/2011 Consumer United States
Primary
Secondary
Cataract Other Serious 75 Male 12/2/2011 Consumer Canada
Primary
Secondary
Concomitant
Intraocular Pressure Increased Other Serious 8/1/2011 76 Female 90 lb 12/2/2011 Physician United States
Primary
Secondary
Concomitant
Throat Irritation Other Serious 10/1/2011 65 Female 12/2/2011 Pharmacist Canada
Primary
Secondary
Concomitant
Urticaria 92 Female 12/8/2011 Consumer United States
Primary
Secondary
Rash Generalised Other Serious 10/1/2011 65 Female 12/8/2011 Pharmacist Canada
Primary
Secondary
Concomitant
Diplopia Other Serious 1/1/2011 82 Female 12/12/2011 Consumer Canada
Primary
Secondary
Concomitant
Arthralgia Other Serious 9/1/2011 63 Female 225 lb 12/13/2011 Physician United States
Primary
Concomitant
Glaucoma Other Serious 9/26/2011 65 Male 12/14/2011 Pharmacist Japan
Primary
Concomitant
Drug Ineffective Other Serious 8/1/2011 76 Female 90 lb 12/15/2011 Physician United States
Primary
Secondary
Concomitant
Drug Hypersensitivity 10/8/2011 92 Female 12/15/2011 Consumer United States
Primary
Secondary
Intraocular Pressure Increased Other Serious Male 12/21/2011 Consumer United States
Primary
Secondary
Concomitant
Rash Generalised Other Serious 10/1/2011 65 Female 12/20/2011 Pharmacist Canada
Primary
Secondary
Concomitant
Incorrect Dose Administered Male 145 lb 12/21/2011 Consumer United States
Primary
Secondary
Concomitant
Depression Other Serious 1/1/2010 Male 12/26/2011 Consumer Australia
Primary
Secondary
Night Blindness Other Serious 10/1/2009 66 Female 169 lb 12/26/2011 Physician United States
Primary
Secondary
Eye Irritation 12/27/2011 Other Health Professional United States
Primary
Secondary
Visual Acuity Reduced Other Serious 9/26/2011 65 Male 1/3/2012 Pharmacist Japan
Primary
Concomitant
Intraocular Pressure Increased Other Serious 12/29/2011 Female 1/4/2012 Consumer United States
Primary
Secondary
Amblyopia Other Serious 1/1/2011 82 Female 1/6/2012 Consumer Canada
Primary
Secondary
Concomitant
Drug Hypersensitivity 10/8/2011 92 Female 1/9/2012 Consumer United States
Primary
Secondary
Paraesthesia Other Serious 10/1/2011 65 Female 1/10/2012 Pharmacist Canada
Primary
Secondary
Concomitant
Eye Irritation 10/8/2011 92 Female 1/26/2012 Other Health Professional United States
Primary
Secondary
Eye Irritation Male 1/27/2012 Consumer United States
Primary
Secondary

Drug Data